KRAS and cancer: The PPI network for compounds 2–6 is visualized in Figure 8A. Importantly, TP53, PTEN, ATM, BRCA1, KRAS, CTNNB1, AKT, CDKN2A, ERBB2, and BRCA2 were identified as core compounds 2–5-associated targets in cancer.